EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   5.1.3.17 | Breast Neoplasms |
17985344 |
Decreased expression of human D-glucuronyl C5-epimerase in breast cancer. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
3
4
0 |
| 5.1.3.17 | Breast Neoplasms |
20723247 |
Antiproliferative effect of D-glucuronyl C5-epimerase in human breast cancer cells. |
ongoing research
unassigned |
4
0 |
| 5.1.3.17 | Breast Neoplasms |
22805760 |
The TCF4/?-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer. |
unassigned |
0 |
| 5.1.3.17 | Carcinogenesis |
24264315 |
D-glucuronyl C5-epimerase cell type specifically affects angiogenesis pathway in different prostate cancer cells. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
3
1 |
| 5.1.3.17 | Carcinogenesis |
28734894 |
GLCE rs3865014 (Val597Ile) polymorphism is associated with breast cancer susceptibility and triple-negative breast cancer in Siberian population. |
unassigned |
0 |
| 5.1.3.17 | Lung Neoplasms |
21654676 |
D-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
3
1
0 |
| 5.1.3.17 | Mastocytoma |
6420398 |
Biosynthesis of heparin. Substrate specificity of heparosan N-sulfate D-glucuronosyl 5-epimerase. |
ongoing research
unassigned |
3
0 |
| 5.1.3.17 | Mastocytoma |
6768743 |
Biosynthesis of heparin. Partial purification of the uronosyl C-5 epimerase. |
unassigned |
0 |
| 5.1.3.17 | Mastocytoma |
10642607 |
Biosynthesis of heparin/heparan sulfate: kinetic studies of the glucuronyl C5-epimerase with N-sulfated derivatives of the Escherichia coli K5 capsular polysaccharide as substrates. |
ongoing research
unassigned |
2
0 |
| 5.1.3.17 | Neoplasms |
21654676 |
D-glucuronyl C5-epimerase suppresses small-cell lung cancer cell proliferation in vitro and tumour growth in vivo. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
3
1
0 |
